Female sexual dysfunction and antidepressant use.
Terao
T
T
D000547:Amantadine / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002065:Buspirone / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D017374:Paroxetine / Q000627:therapeutic use; D010555:Personality Inventory / Q000706:statistics & numerical data; D010919:Placebos; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced* / Q000188:drug therapy*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D010919:Placebos; D005473:Fluoxetine; D015283:Citalopram; D017374:Paroxetine; D000547:Amantadine; D002065:Buspirone